SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents.
Critical reviews in oncology/hematology. 2020 May 12 [Epub ahead of print]
Anya Jafari, Sahar Dadkhahfar, Sahra Perseh
Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: ., Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.